Capxcel Film Coated Tablet 500 mg/tablet

Država: Tanzanija

Jezik: engleski

Izvor: Tanzania Medicinces & Medical Devices Authority

Aktivni sastojci:

Capecitabine

Dostupno od:

Khandelwal Laboratories Private Limited, INDIA

ATC koda:

Antimetabolites

INN (International ime):

Capecitabine

Doziranje:

500 mg/tablet

Farmaceutski oblik:

Film Coated Tablet

Proizveden od:

Khandelwal Laboaratories Private Limited, INDIA

Proizvod sažetak:

Physical description: Biconvex circular buff coloured film coated tablets; Local technical representative: Salama Pharmaceuticals Limited

Status autorizacije:

Registered/Compliant

Datum autorizacije:

2021-06-03

Svojstava lijeka

Effective date: 03/10/2022
TMDA/DMC/MRE/F/016
REV #:02
THEUNITEDREPUBLICOFTANZANIA
MINISTRYOFHEALTH
TANZANIAMEDICINES ANDMEDICALDEVICESAUTHORITY
PUBLIC ASSESSMENT REPORT FOR CAPXCEL (CAPECITABINE 500 MG) FILM
COATED TABLETS
VERSION NUMBER 01
3
RD JANUARY, 2022
TMDA HEADQUARTERS, PLOT NO. 56/1, BLOCK E, KISASA B CENTRE, SWASWA
ROAD, P. O. BOX
1253, DODOMA – TANZANIA, TELEPHONE: [phone]/+255
(22)
2450512/2450751/2452108, EMAIL: [e-mail], Website:
WWW.TMDA.GO.TZ
Toll free: 0800110084
Effective date: 03/10/2022
1
1.
INTRODUCTION
Capxcel is a generic medicine of Xeloda. Capxcel is a non-cytotoxic
fluoropyrimidine
carbamate medicine belonging to L01BC06 cytostatic (antimetabolite)
group. Capxcel is
a precursor of the cytotoxic moiety 5-fluorouracil (5-FU).
Capecitabine is activated via
several
enzymatic
steps.
The
enzyme
involved
in
the
final
conversion
to
5-FU,
thymidine phosphorylase (ThyPase), is found in tumour tissues, but
also in normal
tissues, albeit usually at lower levels. In human cancer xenograft
models capecitabine
demonstrated a synergistic effect in combination with docetaxel, which
may be related
to the upregulation of thymidine phosphorylase by docetaxe. Capxcel is
approved in
Tanzania for use in adults.
1.1 PRODUCT DETAILS
Registration number
TAN 21 HM 0225
Brand name
Capxcel
Generic
name,
strength
and
form
Capecitabine 500 mg film coated tablets
ATC classification
L01BC06 cytostatic (antimetabolite)
Distribution category
POM
Country of origin
India
Associated product
State any other product of formulation, strength or
site that is linked or associated with the product if
applicable
Marketing Authorization Holder
Khandelwal Laboratories Pvt., Ltd
79/87, D.Lad Path, Mumbai - 400033,
India
E-MAIL:[e-mail]
Local
Technical
Representative
Salama Pharmaceuticals Ltd.
Plot No. 4, block 28, Aggrey/Nyamwezi Street, Kariakoo,
Dar es Salaam, Tanzania
1.2
ASSESSMENT PROCEDURE
The application for registration of Capxcel was submitted on 11
th
April, 2019. The
product und